Evidence map›Paper›PMID 37108561›Full record

ArticleInternational journal of molecular sciences2023

Prognostic Factors Affecting Death in Patients with Rheumatoid Arthritis Complicated by

Hideyuki Shiba, Takuya Kotani, Koji Nagai, Kenichiro Hata, Wataru Yamamoto, Ayaka Yoshikawa, Yumiko Wada, Yuri Hiramatsu, Hidehiko Makino, Yo Ueda and 10 more

Open access · goldAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Machine Learning Models for Prediction of SevereDiagnostics (Basel, Switzerland) · 2023
    Article
  5. Risk Factors forJournal of fungi (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 1 country.

Hideyuki ShibaDepartment of Internal Medicine (IV), Division of Rheumatology, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.
Takuya KotaniDepartment of Internal Medicine (IV), Division of Rheumatology, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.
Koji NagaiDepartment of Internal Medicine (IV), Division of Rheumatology, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.
Kenichiro HataDepartment of Internal Medicine (IV), Division of Rheumatology, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.
Wataru YamamotoDepartment of Health Information Management, Kurashiki Sweet Hospital, Okayama 710-0016, Japan.
Ayaka YoshikawaDepartment of Internal Medicine (IV), Division of Rheumatology, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.
Yumiko WadaDepartment of Internal Medicine (IV), Division of Rheumatology, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.
Yuri HiramatsuDepartment of Internal Medicine (IV), Division of Rheumatology, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.
Hidehiko MakinoDepartment of Internal Medicine (IV), Division of Rheumatology, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.
Yo UedaDepartment of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Akira OnishiDepartment of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan.ORCID 0000-0002-3120-1273
Koichi MurataDepartment of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto 606-8303, Japan.
Hideki AmuroFirst Department of Internal Medicine, Kansai Medical University, Osaka 573-1191, Japan.
Yonsu SonFirst Department of Internal Medicine, Kansai Medical University, Osaka 573-1191, Japan.
Ryota HaraRheumatology Clinic and Department of Orthopaedic Surgery, Nara Medical University, Nara 634-8521, Japan.
Toru HiranoDepartment of Rheumatology, Nishinomiya Municipal Central Hospital, Nishinomiya 663-8014, Japan.ORCID 0000-0001-8467-3154
Kosuke EbinaDepartment of Musculoskeletal Regenerative Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.ORCID 0000-0002-2426-1024
Masaki KatayamaDepartment of Rheumatology, Osaka Red Cross Hospital, Osaka 543-0027, Japan.
Motomu HashimotoDepartment of Clinical Immunology, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan.
Tohru TakeuchiDepartment of Internal Medicine (IV), Division of Rheumatology, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.
Osaka University of Pharmaceutical Sciences · JPKansai Medical University · JPKyoto University · JPKobe University · JPKurashiki Central Hospital · JPNara Medical University · JPNishinomiya Municipal Central Hospital · JPOsaka Metropolitan University · JPOsaka Red Cross Hospital · JPThe University of Osaka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This multicenter retrospective study aimed to clarify the prognostic factors for mortality and changes in treatment modalities and disease activities after the onset of

Indexed as

Arthritis, RheumatoidPneumocystis cariniiPneumonia, PneumocystisAgedCohort StudiesFemaleHumansMalePrednisolonePrognosisRetrospective StudiesPrednisolonePneumocystis jirovecii pneumoniaprognosisrheumatoid arthritis

Identifiers

PMID37108561
PMCPMC10138913
OpenAlexW4366286703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.